Twist Bioscience launches analysis panel for screening COVID-19, different respiratory viruses


Artificial DNA producer Twist Bioscience launched a brand new analysis panel centered on figuring out respiratory ailments, together with the novel coronavirus behind the COVID-19 pandemic.

Utilizing a next-generation sequencing strategy, the panel can detect a spread of coronaviruses in addition to rhinoviruses, adenoviruses, enteroviruses, respiratory syncytial virus and completely different strains of influenza in a single pattern—29 frequent human respiratory viruses in all.

“The signs of COVID-19 are extraordinarily various, in lots of circumstances mimicking quite a few different frequent sicknesses together with influenza, adenovirus infections and even the frequent chilly,” said Twist’s co-founder and CEO, Emily Leproust, Ph.D. 

Webinar

De-risking the Improvement of Biotherapeutics Utilizing Early Stage In Vitro Expression and Genetic Characterisation Instruments

There’s a excessive attrition price throughout the improvement of biotherapeutics impacting the excessive price of improvement. Early identification of the popular expression host for manufacturing, together with lead candidate screening and materials provide may help to cut back each attrition charges and price.

“By providing a complete respiratory panel with the power to detect and characterize a variety of viruses, this assay offers an essential instrument that matches inside a number of workflows to appropriately determine and analysis the underlying virus inflicting the an infection or co-infection,” Leproust stated. 

RELATED: Twist Bioscience secures $140M plus a slew of new DNA partnerships

Although not a medical diagnostic check itself, the analysis use solely panel can be utilized to assist “surveil populations for early indicators of outbreak, viral transmission and evolution to reinforce public well being response,” she added, together with each DNA- and RNA-based viruses in a single equipment.

Earlier this month, Twist expanded its providing of artificial SARS-CoV-2 RNA controls used to assist develop and validate coronavirus diagnostic assessments. These embody 4 new variants of the novel coronavirus’s genetic materials, together with mutations seen in several geographic areas.



Source link

JOIN OUR COMMUNITY OF 10,000+ SUBSCRIBERS!
We hate spam and promise to keep your email address safe!
Tagged : / / / / / / / /

Leave a Reply

Your email address will not be published. Required fields are marked *